Clinical Research Directory
Browse clinical research sites, groups, and studies.
The BARCODE 1 Pilot Study
Sponsor: Institute of Cancer Research, United Kingdom
Summary
BARCODE 1 is a screening study designed to investigate the role of genetic profiling for targeting population prostate cancer screening. This study forms a pilot of 300 men, with the view to continue to a future study of 5000 men.
Official title: The BARCODE 1 Pilot Study: The Use of Genetic Profiling to Guide Prostate Cancer Targeted Screening
Key Details
Gender
MALE
Age Range
55 Years - 69 Years
Study Type
OBSERVATIONAL
Enrollment
329
Start Date
2016-04-29
Completion Date
2028-12-31
Last Updated
2025-09-26
Healthy Volunteers
Yes
Conditions
Interventions
Genetic SNP profiling
Genetic SNP profiling of known prostate cancer predisposition SNPs will be performed on DNA extracted from saliva samples.
Prostate cancer screening
Prostate cancer screening in the form of PSA testing will be offered to all men who have a benign biopsy result for five years in order to track development of cancer in the future.
Prostate biopsy
Prostate biopsy will be offered to men identified within the top 10% genetic risk score profile.
Locations (1)
Institute of Cancer Research and Royal Marsden Hospital
Sutton, Surrey, United Kingdom